The Jan. 12, 2017, joint meeting of the NCATS Advisory Council and the Cures Acceleration Network (CAN) Review Board featured the following meeting materials.
Presentations
- NCATS Director's Report (PDF - 2MB) Christopher P. Austin, M.D., director, NCATS
- CAN Review Board Update (PDF - 240KB) Freda C. Lewis-Hall, M.D., chief medical officer, Pfizer
- Office of Rare Diseases Update (PDF - 2MB) Petra Kaufmann, M.D., M.Sc., director, Office of Rare Diseases Research and the Division of Clinical Innovation, NCATS